v3.26.1
CASH EQUIVALENTS AND MARKETABLE SECURITIES
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
CASH EQUIVALENTS AND MARKETABLE SECURITIES

NOTE 4 – CASH EQUIVALENTS AND MARKETABLE SECURITIES

 

The Company invests primarily in U.S. Treasury securities and U.S. government agency securities. The following tables present the Company’s cash equivalents and marketable securities by significant investment category as of June 30, 2026:

                                  
                      Reported As 
Assets  Pricing Category  Amortized Cost   Unrealized Gain   Unrealized Loss   Fair Value   Cash Equivalents   Marketable Securities 
Money Market Funds  Level 1   218,396            218,396    218,396     
U.S. Treasury Securities  Level 2   51,843,362        (32,488)   51,810,874    16,942,860    34,868,014 
U.S. Agency Securities  Level 2   17,828,933        (16,413)   17,812,520    3,978,720    13,833,800 
Total      69,890,691        (48,901)   69,841,790    21,139,976    48,701,814 

  

Accrued interest receivable of $254,288 is excluded from the amortized cost basis of the available-for-sale debt securities and is included in prepaid expenses and other current assets in the accompanying balance sheet.

 

As of June 30, 2026, all available-for-sale marketable securities were in unrealized loss positions; however, the Company concluded that the unrealized losses were attributable to changes in market interest rates and not to credit-related factors. Accordingly, no allowance for credit losses was recorded as of June 30, 2026. In addition, none of the securities had been in a continuous unrealized loss position for more than 12 months.

 

As of June 30, 2026, all of the Company’s available-for-sale marketable securities had contractual maturities of less than one year. The Company did not hold any marketable securities or cash equivalents classified as available-for-sale debt securities as of December 31, 2025.